Targeted Disruption of Mouse Fibroblast Activation Protein
AUTOR(ES)
Niedermeyer, J.
FONTE
American Society for Microbiology
RESUMO
Human fibroblast activation protein (FAP), a member of the serine prolyl oligopeptidase family, is a type II cell surface glycoprotein selectively expressed by fibroblastic cells in areas of active tissue remodeling, such as the embryonic mesenchyme, areas of wound healing, the gravid uterus, and the reactive stroma of epithelial cancers. Homologues of FAP have been identified in the mouse and Xenopus laevis. FAP is a dual-specificity enzyme that acts as a dipeptidyl peptidase and collagenase in vitro. To explore the role of FAP in vivo, Fap−/− mice were generated by homologous recombination. RNase protection analysis and reverse transcription-PCR confirmed the absence of full-length Fap transcripts in mouse embryonic tissues. No FAP protein was detected in Fap−/− animals by immunohistochemistry, and no FAP-specific dipeptidyl peptidase activity was found. We report that Fap−/− mice are fertile, show no overt developmental defects, and have no general change in cancer susceptibility.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=85226Documentos Relacionados
- Targeted Disruption of the Mouse Mel1b Melatonin Receptor
- Targeted disruption of mouse centromere protein C gene leads to mitotic disarray and early embryo death
- Targeted Disruption of the Mouse PAS Domain Serine/Threonine Kinase PASKIN
- Targeted disruption of the mouse topoisomerase I gene by camptothecin selection.
- Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia
